What is the standard INR goal for most patients?

The standard INR (International Normalized Ratio) goal for most patients is typically set between 2.0 and 3.0. This range is generally considered optimal for patients who are receiving anticoagulation therapy, particularly those being treated for conditions like atrial fibrillation, venous thromboembolism, or patients with mechanical heart valves. Maintaining the INR within this range strikes a balance between reducing the risk of thromboembolic events while minimizing the risk of bleeding complications associated with higher INR levels.

Specific therapeutic goals can vary based on individual patient factors and the underlying conditions being treated, but for the majority of patients on anticoagulants, the 2.0-3.0 range is well-established and supported by clinical guidelines, making it the standard target for monitoring therapy effectiveness and safety.